Jamil Abuzetun is a Cardiology physician affiliated with Creighton University. OpenAlex indexes 21 publications with 239 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
20805 W 151st St # 400
Olathe, KS 660617249
Telephone
913-780-4900Provider last certified this registry record 8 May 2026.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20255 payments
- Medtronic, Inc.Program year20252 payments
- Impulse Dynamics (USA) Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
82.9%Beta blocker21.3%Metoprolol Succinate56%Carvedilol27%Metoprolol Tartrate10%Bisoprolol Fumarate5%Sotalol2%Part D<11 patientsStatin18.7%Atorvastatin Calcium70%Rosuvastatin Calcium25%Pravastatin Sodium3%Livalo2%Part D<11 patients+ 15 more classes in this area
Blood & clotting
13.3%Factor Xa inhibitor8.9%Eliquis94%Xarelto6%Part D<11 patientsP2Y12 inhibitor2.7%Clopidogrel84%Brilinta16%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.8%Potassium supplement2.2%Potassium Chloride100%Part D≥30 patientsSGLT2 inhibitor1.1%Farxiga54%Jardiance47%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Efficacy and safety of transulnar coronary angiography and interventions—A single center experience
Catheterization and Cardiovascular Interventions
2013 - SAFETY AND FEASIBILITY OF SAME–DAY PCI AND CAROTID ARTERY STENTING
Journal of the American College of Cardiology
2013 - Single-center 1-year outcomes of carotid artery stenting
Cardiovascular revascularization medicine
2011 - Naproxen-induced ST-elevation myocardial infarction in a 33-year-old man
Journal of Cardiovascular Medicine
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Beart, MD
Creighton University
Alan Thorson, MD
Creighton University
Aryan Mooss, MD
Creighton University
Ross Bremner, MD
Creighton University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”